CLINICAL_TRIALS
trial_result
· 2020-02-12
Clinical Trial Update: Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR) [Phase 4]
Summary
Phase 4 trial update on long-term sulfonylurea response in ABCC8 neonatal diabetes (SuResponsSUR).
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Haukeland University Hospital | Conditions: Permanent Neonatal Diabetes Mellitus | Phase 4 | Status: UNKNOWN